Evidence map›Paper›PMID 27121948›Full record

ArticleThe American journal of clinical nutrition2016

Elevations in serum anti-flagellin and anti-LPS Igs are related to growth faltering in young Tanzanian children.

Christine M McDonald, Karim P Manji, Kerri Gosselin, Hao Tran, Enju Liu, Rodrick Kisenge, Said Aboud, Wafaie W Fawzi, Andrew T Gewirtz, Christopher P Duggan

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00421668 phase3completednot on this map

A Trial of Zinc and Micronutrients in Tanzanian Children

TypeinterventionalSponsorHarvard School of Public Health (HSPH)Ran2007 to 2012Enrolled2,400ConditionsDiarrheal Illnesses, Respiratory Illness, Growth FalteringArmsZinc, Multivitamins, Placebo
NCT06676215 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Efficacy of Amino Acid Supplementation on Gut Function and Nutritional Status in FIlipino Children Below Three Years Old

TypeinterventionalSponsorFood and Nutrition Research Institute, PhilippinesRan2025 to 2025Enrolled60ConditionsStunted GrowthArmsIAA mix supplement, Complementary food comprised of rice and legumes
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  15. Article
  16. Campylobacter jejuni virulence genes and immune-inflammatory biomarkers association with growth impairment in children from Northeastern Brazil.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Christine M McDonaldDivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA;
Karim P ManjiPediatrics and Child Health and.
Kerri GosselinDivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA;
Hao TranInstitute for Biomedical Sciences, Georgia State University, Atlanta, GA; and.
Enju LiuDepartments of Global Health and Population.
Rodrick KisengePediatrics and Child Health and.
Said AboudMicrobiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania;
Wafaie W FawziDepartments of Global Health and Population, Epidemiology, and Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
Andrew T GewirtzInstitute for Biomedical Sciences, Georgia State University, Atlanta, GA; and.
Christopher P DugganDivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA; Departments of Global Health and Population, Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA christopher.duggan@childrens.harvard.edu.ORCID 0000-0001-8083-8193
Boston Children's Hospital · USGeorgia State University · USHarvard University · USInstitute of Population, Health and Development · VNMuhimbili University of Health and Allied Sciences · TZ

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
TRAINING IN PEDIATRIC GASTROENTEROLOGY &NUTRITIONT32DK007477 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI Scott B Snapper · 1986 to 2026
$13.3M
A Trial of Zinc and Micronutrients in Tanzanian ChildrenR01HD048969 · NICHD · HARVARD SCHOOL OF PUBLIC HEALTH · PI DUGGAN, CHRISTOPHER P · 2006 to 2010
$2.0M
Patient-oriented Research in Pediatric Diarrheal DiseasesK24DK104676 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI DUGGAN, CHRISTOPHER P · 2015 to 2019
$903k
NICHD NIH HHS R01 HD048969NIDDK NIH HHS K24 DK104676NIDDK NIH HHS P30 DK034854NIDDK NIH HHS P30 DK040561NIDDK NIH HHS T32 DK007477
6 · The paper itself

Abstract

backgroundAntibodies to LPS and flagellin have been described as indirect measures of increased gastrointestinal permeability and may be markers of environmental enteric dysfunction (EED), which is a condition associated with poor child growth.

objectiveWe assessed whether LPS- and flagellin-specific immunoglobulin (Ig) concentrations were associated with poor growth in young Tanzanian children at risk of EED.

designBlood samples were obtained from 590 children at 6 wk, 6 mo, and 12 mo of age. Serum LPS- and flagellin-specific Ig concentrations (IgA and IgG) were measured with the use of an ELISA. Growth was measured on a monthly basis for 18 mo.

resultsAnti-LPS and anti-flagellin IgA and IgG concentrations increased over the first year of life and were higher than concentrations (measured at 9 mo of age) in healthy controls. Children with anti-flagellin IgA, anti-LPS IgA, anti-flagellin IgG, and anti-LPS IgG concentrations in the highest quartile at 6 wk of age were 2.02 (95% CI: 1.11, 3.67), 1.84 (95% CI: 1.03, 3.27), 1.94 (95% CI: 1.04, 3.62), and 2.31 (95% CI: 1.25, 4.27) times, respectively, more likely to become underweight (weight-for-age z score <-2) after adjustment for covariates (P-trend < 0.05) than were children with Ig concentrations in the lowest quartile. Children with increased concentrations of anti-flagellin IgA were also more likely to become wasted; however, there was no association between any of the markers and subsequent stunting.

conclusionSerologic measures of increased intestinal permeability to bacterial components are associated with subsequent poor growth and could help identify children who may benefit most from preventive interventions. This trial was registered at clinicaltrials.gov as NCT00421668.

Indexed as

Body WeightEnvironmentFemaleFlagellinGastrointestinal AbsorptionGastrointestinal DiseasesGrowth DisordersHumansImmunoglobulin AImmunoglobulin GInfantIntestinesLipopolysaccharidesLongitudinal StudiesMaleTanzaniaFlagellinImmunoglobulin AImmunoglobulin GLipopolysaccharidesanti-flagellin antibodiesanti-LPS antibodieschild growthenvironmental enteric dysfunctionenvironmental enteropathyintestinal biomarkersintestinal permeability

Identifiers

PMID27121948
PMCPMC4881001
OpenAlexW2344527037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.